Tsai KY, Lee CC, Chou YM, et al. The incidence and relative risk of stroke in patients with schizophrenia: a five-year follow-up study

Department of Community Psychiatry, Kai-Suan Psychiatric Hospital, Kaohsiung City, Taiwan.
Schizophrenia Research (Impact Factor: 3.92). 03/2012; 138(1):41-7. DOI: 10.1016/j.schres.2012.02.013
Source: PubMed


This study aimed to estimate the incidence and relative risk of stroke and post-stroke all-cause mortality in patients with schizophrenia.
This study identified a study population from the National Health Insurance Research Database (NHIRD) between 1999 and 2003 that included 80,569 patients with schizophrenia and 241,707 age- and sex-matched control participants without schizophrenia. The participants were randomly selected from the 23,981,020-participant NHIRD, which consists of 96% Taiwanese participants. Participants who had experienced a stroke between 1999 and 2003 were excluded. Using data from the NHIRD between 2004 and 2008, the incidence of stroke (ICD-9-CM code 430-438) and patient survival after stroke were calculated for both groups. After adjusting for confounding risk factors, a Cox proportional-hazards model was used to compare the five-year stroke-free survival rate to the all-cause mortality rate across the two cohorts.
Over five years, 1380 (1.71%) patients with schizophrenia and 2954 (1.22%) controls suffered from strokes. After adjusting for demographic characteristics and comorbid medical conditions, patients with schizophrenia were 1.13 times more likely to have a stroke (95% CI=1.05-1.22; P=0.0006). In addition, 1039 (24%) patients who had a stroke died during the follow-up period. After adjusting for patient, physician and hospital variables, the all-cause mortality hazard ratio for patients with schizophrenia was 1.23 (95% CI=1.06-1.41; P=0.0052).
During a five-year follow-up, the likelihood of developing a stroke and the all-cause mortality rate were greater among patients with schizophrenia as compared with the control group.

Download full-text


Available from: Frank Huang-Chih Chou, Feb 19, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We provide a review of both clinical and basic science literature from 2012 relevant to care of the patient with neurological disease. Our review addresses the following major areas: general neurosurgical procedures, stroke, traumatic brain injury, spine surgery, anesthetic neurotoxicity, neuroprotective strategies, electrophysiological monitoring, history, and graduate medical education. We have focused on research describing new and innovative concepts and recurring themes. This review is intended to be of interest to those working in the clinical arena and also to neuroscientists.
    Journal of neurosurgical anesthesiology 04/2012; 24(2):85-112. DOI:10.1097/ANA.0b013e31824a8152 · 2.99 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Recent evidence suggests that psychiatric and/or psychological factors could be independent risk factors for stroke. Some of these factors may act as stroke triggers producing short-term physiological changes that may directly lead to stroke onset. Most data is related to four distinct domains: (1) depression and/or anxiety and related syndromes, (2) personality and character traits, (3) psychological stress, and (4) psychotropic medication. Some factors (e.g., depression) are closely related to stroke risk, and there is some evidence that psychological stress could be an important risk factor. However, many studies have methodological limitations (small sample size, lack of adjustment for stroke risk factors, or residual confounding) and lack of standardized definition and/or measurement. Data about stroke triggers is scarce but epidemiological studies suggest a triggering effect of acute or subacute life stress exposure. The potential pathophysiological ways by which psychiatric and/or psychological factors may promote stroke include a higher frequency of unhealthy behaviors and direct biological effects on the cardiovascular system, notably through activation of the sympathetic nervous system. More research is still needed to improve measurement and to better investigate the impact of psychiatric and/or psychological factors. The clarification of pathophysiological mechanisms could help to consider preventive strategies.
    Neuropsychiatric Symptoms of Cerebrovascular Diseases, 01/2013: pages 255-297;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: This study sought to estimate the incidence, all-cause mortality and relative risks for patients with schizophrenia after a pneumonia diagnosis. Methods: The population was identified from the Taiwanese National Health Insurance Research Database (NHIRD) in 1999 and included 59,021 patients with schizophrenia and 236,084 age- and sex-matched control participants without schizophrenia. These participants were randomly selected from the 23,981,020-participant NHIRD, which contain 96% of the entire population. Using the 2000-2008 NIHRD, the incidence and nine-year pneumonia-free survival rate of pneumonia (ICD-9-CM codes 486 and 507.0-507.8) were calculated. Results: Over nine years, 6055 (10.26%) patients with schizophrenia and 7844 (3.32%) controls had pneumonia. The pneumonia incidence density was 11.4/1000 person-years among the patients with schizophrenia, who experienced a 3.09-fold increased risk of developing pneumonia. After adjusting for other covariates, the patients with schizophrenia still experienced a 1.77-fold increased risk of developing pneumonia. Although, without adjustment, fewer schizophrenia patients than controls died after having pneumonia (2121 [35.12%] vs. 3497 [44.62%]), after adjusting for other variables, the mortality hazard ratio for patients with schizophrenia was 1.39. Conclusions: During a nine-year follow-up, the likelihood of developing pneumonia and all-cause mortality among patients with schizophrenia was higher than that of the non-schizophrenia group as was the mortality rate. Interestingly, the psychiatric proportion of days covered (PDC) was positively associated with pneumonia (OR: 2.51) but negatively associated with death (HR: 0.72). These findings imply the importance of iatrogenic factors and psychotropic drugs (including their benefits and side effects) and highlight the directions for future studies.
    Journal of Psychiatric Research 01/2013; 47(4). DOI:10.1016/j.jpsychires.2012.12.007 · 3.96 Impact Factor
Show more